Download Your Copy
Prioritizing the Patient Voice with Hybrid Clinical Trials (International Clinical Trials, February 2022)
BBK's Senior Director of Market Expansion, Aaron Fleishman, presents new survey findings that reveal the importance of offering patients choice when it comes to improving clinical trial diversity, access, and engagement.
- Features extensive data from over 2,078 men and women representing a cross section of the population.
Clinical trial sponsors can leverage the findings to shift from traditional clinical trial models to hybrid models with knowledge and confidence.
Note: This article is taken from International Clinical Trials February 2022, pages 14-20. © Samedan Ltd.